- Home
- COCP vs SLAI Comparison
COCP vs SLAI Comparison
Compare COCP & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
SLAI
SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
Current Price
Company Overview
Basic Information| Metric | COCP | SLAI |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | 63 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 15.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | COCP | SLAI |
|---|---|---|
| Price | $1.12 | $0.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 118.8K | 89.7K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,712,091.00 | N/A |
| Revenue This Year | N/A | $8.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.86 | $0.63 |
| 52 Week High | $2.19 | $2.55 |
Technical Indicators
Market Signals| Indicator | COCP | SLAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 45.59 |
| Support Level | $1.00 | $0.66 |
| Resistance Level | $1.27 | $0.87 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 12.50 | 49.97 |
Price Performance
Historical ComparisonAbout COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.